Alleviate Spike Protein Symptoms Safely and Naturally

It’s safe to say that most people have either had a COVID-19 vaccination (or multiple), have had COVID-19, or both. Many questions are in constant circulation about the long-term effects of the vaccination and illness, spike protein persistence, and therapies that can be used to alleviate related symptoms. A promising therapy with scientifically backed research that’s caught our attention is Plaquex IV therapy, an IV drip treatment that was originally formulated for cardiovascular health — what is it and how does it relieve symptoms associated with spike proteins?

What Is Plaquex IV Drip Therapy?

Plaquex is an intravenous infusion of phosphatidylcholine, a natural phospholipid found in every cell membrane. To help alleviate the effects of spike proteins, Plaquex can repair damaged cellular membranes, break down arterial plaque, improve circulation, support detox and liver health, and reduce inflammation in the body. 

Understanding Spike Proteins in COVID-19

During an infection of SARS-CoV-2, spike protein is used by the virus to enter cells in the body. High levels of spike protein fragments have been associated with post-infection effects. COVID-19 vaccinations use a stabilized form of the spike protein to train the immune system against the virus, which is why spike proteins are detectable in the body after immunization. There is some evidence that spike proteins in the body can be causing symptoms associated with Long COVID, such as cognitive symptoms (brain fog, difficulty concentrating, memory issues, etc.), cardiovascular symptoms, inflammatory/systemic symptoms (chronic fatigue, muscle weakness, joint pain, and sleep disturbances) and autonomic/immune symptoms (temperature intolerance, heart rate and blood pressure instability, and flare-ups of autoimmune-like symptoms).

Plaquex IV Therapy for Spike Proteins

Plaquex is a therapeutic formulation of phosphatidylcholine (PC) — a major phospholipid component of cell membranes — that has been used in integrative and cardiovascular medicine settings to support lipid metabolism, membrane repair, and inflammatory balance. Lately, Plaquex has been discussed in the context of supporting recovery from viral-related inflammation and membrane stress attributed to SARS-CoV-2 spike proteins. These discussions often cite phospholipids’ roles in cellular health, suggesting that supplying exogenous PC might help stabilize cell membranes and aid in the clearance of inflammatory byproducts. A handful of in-vitro studies and biochemical reviews highlight how phosphatidylcholine is involved in macrophage function, lipid transport, and the integrity of the pulmonary surfactant system — points that are sometimes extrapolated in speculative articles to propose it could mitigate symptoms attributed to spike protein exposure. However, it’s important to emphasize that these hypotheses are based on theoretical mechanisms or laboratory findings rather than controlled clinical trials demonstrating that Plaquex directly reduces spike proteins, improves virus clearance, or alleviates post-viral symptom clusters in humans.